Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telehealth vs In-Person Assessments in Glioma Patients on Oral Chemotherapy
NCT06625047Phase 4Completed
- Sponsor
- Mayo Clinic
- Start
- Oct 2024
- Primary completion
- Nov 2025
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial, sponsored by Mayo Clinic. Primary endpoint: Patient satisfaction with care delivered up to 6 months. Started Oct 2024; status: completed.
Beyond the preview
Go deeper on NCT06625047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06625047.